SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-28 10:19
Tx date 2024-03-25 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-360,000 vol 		355,556
Filed 2024-03-28 10:19
Tx date 2024-03-25 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
Common Shares
57 - Exercise of rights
+360,000 vol 		537,777
Filed 2024-03-28 10:18
Tx date 2024-03-25 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
Common Shares
57 - Exercise of rights
+177,777 vol 		177,777
Filed 2024-03-28 10:17
Tx date 2019-09-25 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-03-28 10:14
Tx date 2024-03-25 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-177,777 vol 		715,556
Filed 2024-03-28 10:11
Tx date 2024-03-25 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-177,777 vol
Filed 2024-03-28 10:10
Tx date 2024-03-25 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-177,777 vol
Filed 2024-03-18 11:40
Tx date 2024-03-14 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
56 - Grant of rights
+360,000 vol 		893,333
Filed 2024-03-18 11:39
Tx date 2024-03-14 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
56 - Grant of rights
+533,333 vol 		533,333
Filed 2024-03-18 11:26
Tx date 2019-09-25 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-15 14:58
Tx date 2023-08-11 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
+800,000 vol 		2,100,000
Filed 2022-06-22 20:29
Tx date 2022-06-15 		$ENER
NurExone Biologic Inc. (formerly, EnerSpar Corp.) 		Flom, Eyal
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		258,400
Filed 2022-06-22 20:29
Tx date 2022-06-15 		$ENER
NurExone Biologic Inc. (formerly, EnerSpar Corp.) 		Flom, Eyal
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		680,000
Filed 2021-09-05 05:44
Tx date 2021-09-02 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options 		$295,000
+500,000 vol
$0.59 each 		1,300,000
Filed 2020-06-17 08:46
Tx date 2020-06-11 		$INNO
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		800,000
Filed 2019-10-06 03:54
Tx date 2019-09-25 		$
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		600,000
Filed 2019-10-06 03:50
Tx date 2019-09-25 		$
InnoCan Pharma Corporation 		Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,837,500